HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Cefotaxime vs. conventional therapy for the treatment of bacterial meningitis of infants and children.

Abstract
Eighty-five infants and children were prospectively randomized to receive cefotaxime or ampicillin and chloramphenicol for therapy of bacterial meningitis. The two therapy groups of patients were comparable as to sex, age, clinical status on admission, prior administration of antibiotics and etiology. Three infants (7%) died in each therapy group. Mean number of days of positive cerebrospinal fluid cultures, time to defervescence and duration of treatment and of hospital stay and complications developing during treatment were similar for the two treatment regimens. Median cerebrospinal fluid bactericidal titers against the patients' pathogens in cefotaxime-treated patients (1:64) were larger than those in patients who received conventional therapy (1:8). Mild to moderate motor sequelae were more frequent in those given conventional therapy at the time of discharge only, and not at 4 months or longer of follow-up. We conclude that cefotaxime has similar efficacy when compared with conventional therapy for the management of bacterial meningitis in pediatric patients.
AuthorsC M Odio, I Faingezicht, J L Salas, J Guevara, E Mohs, G H McCracken Jr
JournalPediatric infectious disease (Pediatr Infect Dis) 1986 Jul-Aug Vol. 5 Issue 4 Pg. 402-7 ISSN: 0277-9730 [Print] United States
PMID3725653 (Publication Type: Clinical Trial, Comparative Study, Journal Article, Randomized Controlled Trial, Research Support, Non-U.S. Gov't)
Chemical References
  • Chloramphenicol
  • Ampicillin
  • Cefotaxime
Topics
  • Ampicillin (therapeutic use)
  • Cefotaxime (therapeutic use)
  • Child
  • Child, Preschool
  • Chloramphenicol (therapeutic use)
  • Female
  • Humans
  • Infant
  • Male
  • Meningitis (cerebrospinal fluid, complications, drug therapy)
  • Meningitis, Haemophilus (cerebrospinal fluid, complications, drug therapy)
  • Meningitis, Pneumococcal (cerebrospinal fluid, complications, drug therapy)
  • Prospective Studies
  • Random Allocation

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: